These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 19744558)

  • 1. A comparison of different purification methods of aggrecan fragments from human articular cartilage and synovial fluid.
    Struglics A; Larsson S
    Matrix Biol; 2010 Jan; 29(1):74-83. PubMed ID: 19744558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggrecanase cleavage in juvenile idiopathic arthritis patients is minimally detected in the aggrecan interglobular domain but robust at the aggrecan C-terminus.
    Struglics A; Lohmander LS; Last K; Akikusa J; Allen R; Fosang AJ
    Arthritis Rheum; 2012 Dec; 64(12):4151-61; author reply 4162-3. PubMed ID: 22886575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.
    Lark MW; Bayne EK; Flanagan J; Harper CF; Hoerrner LA; Hutchinson NI; Singer II; Donatelli SA; Weidner JR; Williams HR; Mumford RA; Lohmander LS
    J Clin Invest; 1997 Jul; 100(1):93-106. PubMed ID: 9202061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced concentration of COMP (cartilage oligomeric matrix protein) in osteochondral fractures from racing Thoroughbreds.
    Skiöldebrand E; Heinegård D; Eloranta ML; Nilsson G; Dudhia J; Sandgren B; Ekman S
    J Orthop Res; 2005 Jan; 23(1):156-63. PubMed ID: 15607888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive polyarthritis induced in BALB/c mice by aggrecan from normal and osteoarthritic human cartilage.
    Glant TT; Cs-Szabó G; Nagase H; Jacobs JJ; Mikecz K
    Arthritis Rheum; 1998 Jun; 41(6):1007-18. PubMed ID: 9627010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synovial fluid level of aggrecan ARGS fragments is a more sensitive marker of joint disease than glycosaminoglycan or aggrecan levels: a cross-sectional study.
    Larsson S; Lohmander LS; Struglics A
    Arthritis Res Ther; 2009; 11(3):R92. PubMed ID: 19545413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calpain is involved in C-terminal truncation of human aggrecan.
    Struglics A; Hansson M
    Biochem J; 2010 Sep; 430(3):531-8. PubMed ID: 20618160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of the identity of proteolytic aggrecan fragments using PAGE migration and Western immunoblot.
    Struglics A; Larsson S; Lohmander LS
    Osteoarthritis Cartilage; 2006 Sep; 14(9):898-905. PubMed ID: 16635583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Western blot quantification of aggrecan fragments in human synovial fluid indicates differences in fragment patterns between joint diseases.
    Struglics A; Larsson S; Hansson M; Lohmander LS
    Osteoarthritis Cartilage; 2009 Apr; 17(4):497-506. PubMed ID: 19095471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in joint cartilage aggrecan after knee injury and in osteoarthritis.
    Lohmander LS; Ionescu M; Jugessur H; Poole AR
    Arthritis Rheum; 1999 Mar; 42(3):534-44. PubMed ID: 10088777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aggrecan is degraded by matrix metalloproteinases in human arthritis. Evidence that matrix metalloproteinase and aggrecanase activities can be independent.
    Fosang AJ; Last K; Maciewicz RA
    J Clin Invest; 1996 Nov; 98(10):2292-9. PubMed ID: 8941646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
    Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
    Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The structure of aggrecan fragments in human synovial fluid. Evidence that aggrecanase mediates cartilage degradation in inflammatory joint disease, joint injury, and osteoarthritis.
    Lohmander LS; Neame PJ; Sandy JD
    Arthritis Rheum; 1993 Sep; 36(9):1214-22. PubMed ID: 8216415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of synovial fluid markers of cartilage synthesis and turnover to study effects of repeated intra-articular administration of methylprednisolone acetate on articular cartilage in vivo.
    Robion FC; Doizé B; Bouré L; Marcoux M; Ionescu M; Reiner A; Poole AR; Laverty S
    J Orthop Res; 2001 Mar; 19(2):250-8. PubMed ID: 11347698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human aggrecanase generated synovial fluid fragment levels are elevated directly after knee injuries due to proteolysis both in the inter globular and chondroitin sulfate domains.
    Struglics A; Hansson M; Lohmander LS
    Osteoarthritis Cartilage; 2011 Aug; 19(8):1047-57. PubMed ID: 21664283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of increased levels of proteoglycan fragments in synovial fluid (SF) and increased levels of stromelysin in cartilage, synovium and SF by intraarticular injection of canine monocyte conditioned medium into dogs.
    Lark MW; MacNaul KA; Donatelli S; McDonnell J; Hoerrner LA; Stevens KA; Saphos CA; Bayne EK; Hutchinson NI; Moore VL
    J Rheumatol; 1994 Sep; 21(9):1716-24. PubMed ID: 7799356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential levels of synovial fluid aggrecan aggregate components in experimental osteoarthritis and joint disuse.
    Ratcliffe A; Beauvais PJ; Saed-Nejad F
    J Orthop Res; 1994 Jul; 12(4):464-73. PubMed ID: 7520485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An ARGS-aggrecan assay for analysis in blood and synovial fluid.
    Larsson S; Lohmander LS; Struglics A
    Osteoarthritis Cartilage; 2014 Feb; 22(2):242-9. PubMed ID: 24361794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catabolism of aggrecan by explant cultures of human articular cartilage in the presence of retinoic acid.
    Ilic MZ; Mok MT; Williamson OD; Campbell MA; Hughes CE; Handley CJ
    Arch Biochem Biophys; 1995 Sep; 322(1):22-30. PubMed ID: 7574678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of interleukin-1alpha-induced cartilage oligomeric matrix protein degradation in bovine articular cartilage by matrix metalloproteinase inhibitors: potential role for matrix metalloproteinases in the generation of cartilage oligomeric matrix protein fragments in arthritic synovial fluid.
    Ganu V; Goldberg R; Peppard J; Rediske J; Melton R; Hu SI; Wang W; Duvander C; Heinegård D
    Arthritis Rheum; 1998 Dec; 41(12):2143-51. PubMed ID: 9870871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.